Financial results - PHARMACON 99 SRL

Financial Summary - Pharmacon 99 Srl
Unique identification code: 11630621
Registration number: J1999000112398
Nace: 4773
Sales - Ron
251.049
Net Profit - Ron
-1.703
Employees
3
Open Account
Company Pharmacon 99 Srl with Fiscal Code 11630621 recorded a turnover of 2024 of 251.049, with a net profit of -1.703 and having an average number of employees of 3. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmacon 99 Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 104.841 104.156 107.565 122.641 133.562 147.064 173.610 210.834 252.028 251.049
Total Income - EUR 105.813 105.094 107.971 123.277 133.617 147.483 173.614 214.041 252.033 251.052
Total Expenses - EUR 101.749 106.899 108.307 119.164 126.623 139.080 163.193 198.986 246.641 245.849
Gross Profit/Loss - EUR 4.064 -1.804 -336 4.113 6.994 8.403 10.421 15.055 5.392 5.203
Net Profit/Loss - EUR 3.415 -1.804 -1.319 2.889 5.658 7.122 8.720 14.081 3.578 -1.703
Employees 4 4 4 4 4 4 4 4 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 0.2%, from 252.028 euro in the year 2023, to 251.049 euro in 2024. The Net Profit decreased by -3.558 euro, from 3.578 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmacon 99 Srl

Rating financiar

Financial Rating -
PHARMACON 99 SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmacon 99 Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmacon 99 Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmacon 99 Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmacon 99 Srl - CUI 11630621

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 960 741 5.961 5.582 7.166 7.030 7.353 56.935 44.189 31.439
Current Assets 27.731 22.415 24.695 32.913 39.293 35.900 40.796 51.798 47.998 50.350
Inventories 13.095 13.866 15.351 16.124 17.538 19.134 19.681 24.821 25.541 29.029
Receivables 6.381 2.660 6.476 10.566 9.348 11.202 11.956 19.388 13.741 13.646
Cash 8.255 5.888 2.867 6.223 12.406 5.564 9.159 7.588 8.716 7.675
Shareholders Funds 13.080 7.762 6.311 9.084 14.566 15.879 18.688 27.454 30.949 29.073
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 15.611 15.394 24.345 29.411 31.893 27.051 29.461 81.279 61.239 52.717
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 50.350 euro in 2024 which includes Inventories of 29.029 euro, Receivables of 13.646 euro and cash availability of 7.675 euro.
The company's Equity was valued at 29.073 euro, while total Liabilities amounted to 52.717 euro. Equity decreased by -1.703 euro, from 30.949 euro in 2023, to 29.073 in 2024.

Risk Reports Prices

Reviews - Pharmacon 99 Srl

Comments - Pharmacon 99 Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.